title: Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
authors.affiliation: Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Nalesnik
authors.forename: A S
authors.initials: AS
authors.lastname: Rao
authors.forename: A
authors.initials: A
authors.lastname: Zeevi
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: S
authors.initials: S
authors.lastname: Pham
authors.forename: H
authors.initials: H
authors.lastname: Furukawa
authors.forename: A
authors.initials: A
authors.lastname: Gritsch
authors.forename: G
authors.initials: G
authors.lastname: Klein
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D001804:Blood Transfusion, Autologous; D016027:Heart Transplantation; D006801:Humans; D016030:Kidney Transplantation; D015979:Killer Cells, Lymphokine-Activated; D016031:Liver Transplantation; D016040:Lung Transplantation; D017710:Lymphocyte Transfusion; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000628:therapy*; D016377:Organ Transplantation; D011183:Postoperative Complications